跳至主要内容
临床试验/CTRI/2021/02/031579
CTRI/2021/02/031579已完成4 期

Role of prophylactic Tranexamic Acid in reducing blood loss during Cesarean Section: a double blind Placebo Control Randomised Controlled Trial

AIIMS Raipur0 个研究点目标入组 72 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Subjects with singleton pregnancy (parity not more than 3)
  • 2.Age ââ?°Â¥ 18 and < 35 years.
  • 3.ââ?°Â¥ 37 weeks and < 42 weeks of gestation
  • 4.Alive fetus.
  • 5.Hb ââ?°Â¥ 9 g % in recent 3rd trimester report.
  • 6.Subjects receiving spinal anaesthesia for Cesarean Section

排除标准

  • 1.History of venous (deep vein thrombosis and/or pulmonary embolism) or arterial (angina pectoris, myocardial infarction, stroke) thrombosis
  • 2.Subjects with medical disorders like chronic hypertension, renal disease, heart disease, liver disease complicating pregnancy
  • 3.Known case of coagulation disorders
  • 4.Pregnancy related complication like severe preeclampsia, multiple pregnancy, polyhydramnios, and macrosomia, with abnormal placentation, previous two or more caesarean sections
  • 5.Intrauterine death
  • 6.Woman on anticoagulant therapy during the week before delivery
  • 7.Sickle cell disease
  • 8.History of seizures
  • 9.Allergy to TXA.

研究者

发起方
AIIMS Raipur

相似试验